Compare Jayamas Medica Industri Tbk. (OMED) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jayamas Medica Industri Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Jayamas Medica Industri Tbk. trades at Rp214 (market cap 5.79T, 9.53M 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp155 (market cap 314.02B, 49.33M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 18.4× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (49.33M versus 9.53M). Which is the better fit depends on your goals.
| OMED | UVCR | |
|---|---|---|
Market Cap | 5.79T | 314.02B |
Volume | 9.53M | 49.33M |
Lot | 95.3K | 493.25K |
Turnover | 2.05B | 7.55B |
Average Price | 215.03 | 153.12 |
Value | 2.05B | 7.55B |
Indicative Equilibrium Price | 214 | 155 |
Indicative Equilibrium Volume | 1.69K | 3.77K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jayamas Medica Industri Tbk.
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
